After IVF in Lamphel, Imphal: Beta-hCG Follow-Up and First Ultrasound

Bring the embryo transfer date, whether the embryo was transferred at cleavage or blastocyst stage, luteal medicine chart, pregnancy-test results, prior ectopic pregnancy history and any symptoms. The first ultrasound answers questions that serial blood tests cannot, including pregnancy location and observations appropriate to gestational timing.

Do not independently stop progesterone or other prescribed support after the positive test. The clinician should explain how long medicines continue, which team takes over antenatal care and what to do if bleeding, pain or nausea occurs. Not every symptom predicts loss, but alarming symptoms require timely examination.

HomeIVF may be able to coordinate a teleconsultation or selected blood test when medically appropriate and actually available around Imphal. No local home collection or specialist facility is claimed in Lamphel. Ultrasound and urgent assessment require a qualified facility; blood tests and a phone call cannot rule out ectopic pregnancy.

If the fertility centre and pregnancy-care facility are different, ask for a discharge or handover note: transfer date, embryo age, medicine list, laboratory values, relevant risk factors and recommended scan timing. Confirm which service answers urgent questions after the original IVF unit is no longer supervising care.

Early pregnancy follow-up after IVF requires interpretation of more than an hCG curve. The clinical team needs the date and developmental stage of the transferred embryo, the scheduled blood results, relevant previous pregnancy history and the appropriate timing of imaging. A rise in hCG can be reassuring in some circumstances but cannot on its own confirm an intrauterine pregnancy or rule out ectopic pregnancy. Patients should not keep repeating home urine tests to manage uncertainty if a clinician has ordered a different assessment. When the IVF unit is outside Imphal, arrange a named professional who will receive the records and perform the recommended scan at a suitable facility. The handover should explain medications as well as warnings about pain, dizziness or bleeding. Clear responsibility for follow-up is a medical safety issue, not just a travel convenience.

The aim is a reassuringly clear pathway, not repeated testing without purpose. For severe one-sided pain, fainting, shoulder pain, heavy bleeding or any acute concern, seek urgent local medical evaluation rather than waiting for a remote appointment.

A useful local cost comparison separates what is medically necessary from what is offered as an add-on. The proposed centre should price investigations, monitoring, prescribed medicines, procedures and future storage or transfer where applicable. Confirm whether charges change if a cycle is paused or results require a different approach. The estimate should identify the actual facility; it must not imply that HomeIVF operates a branch in this neighbourhood. No home-visit availability, travel distance or fee is assumed.

A trustworthy answer should distinguish a confirmed finding from a possibility, explain what the recommended next action would change, and name the limits of the available evidence. If a test is proposed, ask whether it can alter treatment rather than merely produce more numbers. If a procedure is suggested, request the diagnosis, benefits, risks and alternatives in writing. It is reasonable to seek a second opinion when these questions remain unanswered.